BioWorld

Oct. 13, 2008

View Archived Issues

Stock Winners and Losers For The Week

Public Financing of Biotechnology: September 2008

Other Financings of Public Biotechnology Companies: September 2008

Venture Capital and Other Investments in Private Biotechnology Companies: September 2008

Milestone Payments from Corporate Partners: September 2008

Money Raised in 2008

More Biotech Bankruptcies Might Not Be All Bad

A recent analysis by Jefferies & Co. Inc. of more than 300 loss-making biotechs showed that about 43 percent of the companies are operating with less than a year of cash. (BioWorld Financial Watch) Read More

Money Raised Year to Date

Stock Indexes

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for Dec. 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 16, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery

BioWorld Science

Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...

Illustration of tau accumulating in a neuron cell.

ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

BioWorld

ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...